Wingstop Q3 revenue rises 5.3% to $185.1 million
Wingstop (NASDAQ:WING) reported third-quarter 2026 revenue of $185.1 million, up 5.3% year over year, while net income increased 2.2% to $29.1 million.
Every story in this section, newest first — page 10 of 372.
Wingstop (NASDAQ:WING) reported third-quarter 2026 revenue of $185.1 million, up 5.3% year over year, while net income increased 2.2% to $29.1 million.
Frontier Group Holdings (NASDAQ:ULCC) reported record third-quarter 2026 revenue of $1.4 billion, up 53% year over year, while its GAAP net loss widened to $104 million.
Radware (NASDAQ:RDWR) reported record third-quarter 2026 revenue of $84.4 million, up 12% year over year, while GAAP net income from continuing operations declined to $4.5 million.
HF Sinclair (NYSE:DINO) reported third-quarter 2026 net income of $2.015 billion, or $11.38 per diluted share, compared with $403 million, or $2.15 per share, a year earlier.
Constellium (NYSE:CSTM) reported third-quarter 2026 revenue of $2.639 billion, up 22% year over year, and raised its full-year adjusted EBITDA guidance.
Garmin (NYSE:GRMN) reported record third-quarter 2026 revenue of $1.99 billion, up 12% year over year, and raised its full-year revenue and earnings outlook.
Etsy (NASDAQ:ETSY) reported third-quarter 2026 revenue of $692.47 million, up 10.9% year over year, while adjusted earnings per share reached $1, beating analysts' expectations.
Terex (NYSE:TEX) reported third-quarter 2026 sales of $2.2 billion, up 58.4% as reported and 11.6% on a pro forma basis, while net income increased to $114 million.
Costamare (NYSE:CMRE) reported third-quarter 2026 net income of $88.5 million from continuing operations available to common shareholders, while earnings per share declined to $0.73.
Boston Scientific (NYSE:BSX) reported third-quarter 2026 revenue of $5.138 billion, up 1.5% year over year, while adjusted earnings per share fell short of analysts' expectations at $0.73.
Generac Holdings (NYSE:GNRC) reported record third-quarter 2026 net sales of $1.29 billion, up 16% year over year, as net income increased to $109 million.
Del Monte Corporation (NYSE:DMC) reported third-quarter fiscal 2026 net sales of $1.095 billion, up 7.2% year over year, while adjusted diluted earnings per share reached $0.50.
Aon (NYSE:AON) reported third-quarter 2026 revenue of $4.101 billion, up 3% year over year, while adjusted earnings per share increased 10% to $3.36.
Otis Worldwide (NYSE:OTIS) reported third-quarter 2026 revenue of $3.91 billion and adjusted earnings per share of $1.05, beating analysts' expectations for both measures.
GE Vernova (NYSE:GEV) reported third-quarter 2026 revenue of $12.642 billion, up 26.8% year over year, and raised its full-year revenue and cash flow forecasts.
GE HealthCare (NASDAQ:GEHC) reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year over year, and raised its full-year 2026 financial guidance.
VF Corporation (NYSE:VFC) reported fiscal second-quarter 2027 revenue of $2.695 billion and adjusted diluted earnings per share of $0.70, exceeding its guidance and analysts’ earnings expectations.
Avantor (NYSE:AVTR) reported third-quarter 2026 sales of $1.6983 billion, up 4.6% year over year, and net income of $203.4 million compared with a $711.8 million loss a year earlier.
TE Connectivity (NYSE:TEL) reported fourth-quarter sales of $5.312 billion, up 12% year over year, while GAAP diluted earnings per share from continuing operations rose 39% to $3.10.
Vertiv (NYSE:VRT) reported third-quarter 2026 net sales of $4.313 billion, up 61% year over year, and raised its full-year financial outlook.
OppFi (NASDAQ:OPFI) reported third-quarter 2026 revenue of $149.230 million, while net income fell 54.6% to $34.479 million and diluted earnings per share dropped to $0.40.
New Oriental (NYSE:EDU) reported fiscal first-quarter 2027 revenue of US$1.87 billion, up 23.1% year over year, as operating income and net income also increased.
Group 1 Automotive (NYSE:GPI) reported a 6.7% drop in third-quarter revenue to $5.4 billion.
GSK (NYSE:GSK) reported third-quarter revenue of £8.89 billion, exceeding market expectations due to increased specialty medicine sales.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy